Gisela Paulsen

This profile gathers the share dealings of Gisela Paulsen in Insight Molecular Diagnostics Inc., where the filings describe the role as senior executive. We count 3 filings; the first trade dates from 17 March 2022 and the latest from 1 December 2022.

Purchases make up the whole of the open-market record (1 purchase, €18k). Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 1 share grant.

The newest entry dates from 20 December 2022: a transaction, in Insight Molecular Diagnostics Inc. The clock since the last published purchase (17 March 2022) now reads 1,677 days. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.